Periodontal range from simple gingivitis to serious conditions that cause significant damage to the soft tissues and bones supporting teeth; in a serious case, patients may lose their teeth. According to the World Health Organisation (WHO), as of 2023, ~3.5 billion people are affected with oral diseases across the world. Further, periodontal diseases affect 19% of the adult population, representing more than 1 billion cases. Poor oral hygiene and tobacco chewing are the main risk factors for periodontal disease. As per an article published in the National Library of Medicine (NLM) in 2020, the risk of developing chronic systemic conditions such as autoimmune diseases and cancer increases with periodontitis. Several risk factors linked to periodontitis and oral cancer include smoking, alcohol consumption, and the human papillomavirus. According to the World Cancer Research Fund International, with ~377,700 cases recorded globally in 2020, lips and the oral cavity are the most common sites of mouth and oral cancer.
A periodontal disease can lead to the resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening and falling of the teeth. Therefore, the treatment of periodontal disease focuses on eliminating the source of infection, stimulating the synthesis of growth factors, and repairing periodontal tissue defects, ultimately restoring normal morphology and function. Correcting periodontal defects by bone grafting involves grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the growth of the Europe Dental Bone Graft Substitute and Barrier Membrane Market.
The European Europe Dental Bone Graft Substitute and Barrier Membrane Market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the Europe Dental Bone Graft Substitute and Barrier Membrane Market. Europe occupies a significant position in the Europe Dental Bone Graft Substitute and Barrier Membrane Market and is estimated to register a robust growth rate over the forecast period. The growth of the market in the region is attributed to the large number of procedures performed in the region, large geriatric population, and low costs of procedures in Eastern European countries. In addition, the rising medical tourism in Italy and Spain is likely to influence the market's growth during the forecast period.
Strategic insights for the Europe Dental Bone Graft Substitute and Barrier Membrane provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Europe Dental Bone Graft Substitute and Barrier Membrane refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Europe Dental Bone Graft Substitute and Barrier Membrane Strategic Insights
Europe Dental Bone Graft Substitute and Barrier Membrane Report Scope
Report Attribute
Details
Market size in 2022
US$ 271.56 Million
Market Size by 2030
US$ 517.88 Million
Global CAGR (2022 - 2030)
8.4%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product
By Procedures
By End User
Regions and Countries Covered
Europe
Market leaders and key company profiles
Europe Dental Bone Graft Substitute and Barrier Membrane Regional Insights
Europe Dental Bone Graft Substitute and Barrier Membrane Market Segmentation
The Europe dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user, and country.
Based on product, the Europe dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the Europe dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the Europe dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on country, the Europe dental bone graft substitute and barrier membrane market is segmented into the Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, Matricel GmbH, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, CAMLOG Biotechnologies GmbH, and Resorba Medical GmbH are some of the leading companies operating in the Europe dental bone graft substitute and barrier membrane market.
The Europe Dental Bone Graft Substitute and Barrier Membrane Market is valued at US$ 271.56 Million in 2022, it is projected to reach US$ 517.88 Million by 2030.
As per our report Europe Dental Bone Graft Substitute and Barrier Membrane Market, the market size is valued at US$ 271.56 Million in 2022, projecting it to reach US$ 517.88 Million by 2030. This translates to a CAGR of approximately 8.4% during the forecast period.
The Europe Dental Bone Graft Substitute and Barrier Membrane Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Dental Bone Graft Substitute and Barrier Membrane Market report:
The Europe Dental Bone Graft Substitute and Barrier Membrane Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Dental Bone Graft Substitute and Barrier Membrane Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Dental Bone Graft Substitute and Barrier Membrane Market value chain can benefit from the information contained in a comprehensive market report.